BI 1479-0001 HER2 - Clinical Trial
Who Can Participate in the Study?
Age Group
Adults
Study Details
Full Title
BEAMION-Lung 1: An open label, Phase I dose escalation trial, with dose confirmation and expansion, of BI 1810631 as monotherapy in patients with advanced or metastatic solid tumors with HER2 aberrations. BI1479-0001
Principal Investigator
Medical Oncologist
Protocol Number
IRB:
PRO00113170
NCT:
NCT04886804
Phase
Phase
I
ClinicalTrials.gov
View on ClinicalTrials.gov
Enrollment Status
Open for Enrollment